Status and phase
Conditions
Treatments
About
The study objective is to determine the biomarker status of a participant's tumor tissue and use that status to determine eligibility for a linked Roche clinical trial.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
General Inclusion Criteria:
Inclusion Criteria for Participants with Stage III NSCLC
Inclusion Criteria for Participants with Stage II, IIIA, or Select IIIB (T3N2 only) NSCLC Requiring Adjuvant Treatment
General Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
15,000 participants in 1 patient group
Loading...
Central trial contact
Reference Study ID Number: BX43361 https://forpatients.roche.com
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal